The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 06, 2022

Filed:

May. 03, 2018
Applicant:

Basf Beauty Care Solutions France Sas, Lyons, FR;

Inventors:

Vincent Bardey, Nancy, FR;

Isabelle Bonnet, Lyons, FR;

Anabelle Echard, Luneville, FR;

Nicolas Pelletier, Lyons, FR;

Boris Vogelgesang, Lyons, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/00 (2006.01); A61K 8/9789 (2017.01); A61P 17/00 (2006.01); A61K 36/77 (2006.01); A61Q 19/06 (2006.01); A61Q 19/08 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 8/9789 (2017.08); A61K 36/77 (2013.01); A61P 17/00 (2018.01); A61Q 19/06 (2013.01); A61Q 19/08 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 2236/33 (2013.01); A61K 2800/78 (2013.01);
Abstract

The invention relates to the use of various extracts of theplant for increasing the firmness and/or elasticity of the skin and/or mucous membranes, by increasing type I and/or type V collagen and/or LOX-L, fibulin-5, emiline-1 and/or fibrillin-1 gene and/or protein expression, and/or by decreasing CYR61 expression, in the skin and mucous membranes. Another subject of the invention relates to the use of said extracts in a cosmetic composition comprising at least one cosmetically acceptable excipient. Another subject further relates to a cosmetic care method comprising the application of the extract according to the invention or of a cosmetic composition comprising it, for increasing the firmness and/or elasticity of the skin and/or mucous membranes, by increasing type I and/or type V collagen, fibrillin-1 and/or LOX-L, fibulin-5, emiline-1 and/or fibrillin-1 gene and/or protein expression, and/or by decreasing CYR61 expression, in the skin and mucous membranes. A final subject relates to anextract for use thereof, alone or in a dermatological or pharmaceutical composition, in the prevention and/or treatment of pathological conditions involving a loss of collagen protein and/or gene expression and/or a pathological loss of firmness of the skin and/or mucus membranes, such as rosacea and telangiectasia.


Find Patent Forward Citations

Loading…